|
| INTRODUCTION |
| overview
|| chapter summary || website || RenDER || USRDS database ||
administrative oversight || reading the maps |
|
Download:  Windows  Mac |
| |
| PRÉCIS |
| ESRD
counts & spending || trends in modalities || quality of
care || hospitalization & mortality || ESRD expenditures
|| CKD populations & expenditures |
|
Download: Windows Mac |
| |
| HEALTHY
PEOPLE 2010 |
| incident
rates || cardiovascular disease || fistula use || vaccinations
|| transplantation || diabetes || pre-ESRD diabetic care ||
achievement of HP2010 objectives, by network |
|
Download: Windows Mac |
| |
| CHAPTER
ONE · CHRONIC KIDNEY DISEASE |
| prevalence
|| assessment of at-risk populations || preventive healthcare
monitoring || hospitalization || acute kidney failure || adherence
to prescription drug therapy |
|
Download: Windows Mac |
| |
| CHAPTER
TWO · INCIDENCE & PREVALENCE OF ESRD |
| incidence
|| racial differences in the incidence of ESRD || prevalence
|| incidence & prevalence, by primary diagnosis || rare
diseases || geriatric nephrology || ESRD network populations |
|
Download: Windows Mac |
| |
| CHAPTER
THREE · PATIENT CHARACTERISTICS |
| cardiovascular
comorbidity || adherence to prescription drug therapy || EPO
use & anemia at initiation || biochemical characteristics & BMI
|| predictors of eGFR |
|
Download: Windows Mac |
| |
| CHAPTER
FOUR · TREATMENT MODALITIES |
| incident
modality || prevalent modality || modality & changes over
treatment time || modality & provider characteristics |
|
Download: Windows Mac |
| |
| CHAPTER
FIVE · CLINICAL INDICATORS & PREVENTIVE CARE |
| vascular
access || diabetic care || adherence to prescription drug therapy
in dialysis patients || anemia treatment || anemia management
|| EPO resistance || preventive care |
|
Download: Windows Mac |
| |
| CHAPTER
SIX · MORBIDITY & MORTALITY |
| overall
hospitalization || cause-specific hospitalization || overall
mortality || cause-specific mortality || stroke || peripheral
neuropathy || dementia |
|
Download: Windows Mac |
| |
| CHAPTER
SEVEN · TRANSPLANTATION |
| wait
list || transplant & donation rates || graft survival ||
immunosuppression || post-transplant complications || listings & use
of ECD kidneys || projected wait times |
|
Download: Windows Mac |
| |
| CHAPTER
EIGHT · PEDIATRIC ESRD |
| patient
characteristics || preventive health || vascular access ||
modality || anemia treatment || infectious complications ||
all-cause & cause-specific hospitalization & mortality |
|
Download: Windows Mac |
| |
| CHAPTER
NINE · CARDIOVASCULAR SPECIAL STUDIES |
| demographics & comorbidity
|| AMI in incident & prevalent patients || CHF in incident & prevalent
patients || cardiac arrest in incident & prevalent patients
|| cardiovascular event rates in HD & PD patients || implantable
cardioverter defibrillators || cardiovascular procedure use
in dialysis patients |
|
Download: Windows Mac |
| |
| CHAPTER
TEN · ESRD PROVIDERS |
| provider
growth || patient characteristics, by unit affiliation || provider
compliance with K/DOQI & preventive care guidelines ||
provider differences in preventive care || provider differences
in Bayesian mortality & hospitalization ratios |
|
Download: Windows Mac |
|
|
| |
| CHAPTER
ELEVEN · ECONOMIC COSTS OF ESRD |
| overall
costs of CKD & ESRD || components of costs || ESRD program
expenditures || per person per year expenditures, by modality
|| components of care || vascular access expenditures || Medicare
Advantage (Part C) patients |
|
Download: Windows Mac |
|
|
| |
| CHAPTER
TWELVE · INTERNATIONAL COMPARISONS |
| incidence
|| prevalence || dialysis || transplantation |
|
Download: Windows Mac |
|
|
| |
